BRISTOL MYERS SQUIBB CO (BMY) Factsheet
Earnings-call transcript: none · IR deck: cataloged — watch a real agent read these end-to-end →
BRISTOL MYERS SQUIBB CO (BMY) Stock Analysis
Analysis from 10-Q filed 2025-10-30. Data as of Q2 2026.
Overall Grade: F (Concerning)
Grade F (Concerning). ROIC 14.2%. FCF margin 23.3%. D/E 1.9x. Source: 10-Q filed 2025-10-30.
| Metric | Value | Context |
|---|---|---|
| ROIC | 14.2% | Solid returns |
| FCF Margin | 23.3% | Strong cash generation |
| Debt/Equity | 1.9x | Elevated debt |
ROIC 14.2% — Top 25% of sector peers. FCF margin 23.3% — Top 5%.
Explore BRISTOL MYERS SQUIBB CO: Earnings History | Filings
Programmatic access: Available via MCP at mcp.metricduck.com. Tools for BMY: get_company_overview, get_filing_index (lens: debt_stress, management_outlook, risk_trajectory), get_filing_changes, get_metric_history, compare_companies, screen_filing_signals.
Profitability: BRISTOL MYERS SQUIBB CO earns 14.2% ROIC, Top 25% in Healthcare
ROIC TTM 14.2%, sector median -5.0%, Top 25%. DuPont: NOPAT margin 18.9% × asset turnover 0.5x. Gross margin 70.2%. Operating margin 24.2%. Source: 10-Q filed 2025-10-30.
| Metric | BMY | Rating | Context |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 14.2% | Good | Above sector median of -5.0% |
| Return on Equity (ROE) | 48.2% | Excellent | Efficient use of shareholder equity |
| Gross Margin | 70.2% | Excellent | Strong pricing power |
| Operating Margin | 24.2% | Excellent | Efficient operations |
Cash Flow: BRISTOL MYERS SQUIBB CO generates $11.4B FCF at 23.3% margin, positive NaN/8 quarters
FCF TTM $11.4B. FCF margin 23.3%, Top 5%. OCF/Net income 1.4x. Positive FCF in NaN/8 trailing quarters. Source: 10-Q filed 2025-10-30.
| Metric | BMY | Rating | Context |
|---|---|---|---|
| Free Cash Flow Margin | 23.3% | Excellent | Excellent cash conversion |
| Free Cash Flow (TTM) | $11.4B | Good | Positive cash generation |
| OCF/Net Income | 1.4x | Excellent | High earnings quality |
| FCF Consistency (8Q) | N/A | Warning | Variable cash flow |
Balance Sheet: BRISTOL MYERS SQUIBB CO at 1.9x leverage
Debt/Equity 1.9x. Total debt $43.1B, cash & investments $11.1B. Source: 10-Q filed 2025-10-30.
| Metric | BMY | Rating | Context |
|---|---|---|---|
| Debt to Equity | 1.9x | Warning | Elevated leverage |
| Net Cash Position | $-32.1B | Warning | Net debt position |
Valuation: BRISTOL MYERS SQUIBB CO trades at 12.6x earnings
P/E 12.6x. EV/Sales 2.9x. FCF yield 9.7%. Dividend yield 4.3%. Source: 10-Q filed 2025-10-30.
| Metric | BMY | Rating | Context |
|---|---|---|---|
| P/E Ratio | 12.6x | Adequate | Reasonable valuation |
| EV/Sales | 2.9x | Good | Attractive revenue multiple |
| FCF Yield | 9.7% | Excellent | Attractive cash return |
| Dividend Yield | 4.3% | Good | Meaningful income |
Capital Allocation: BRISTOL MYERS SQUIBB CO returns 4.3% shareholder yield
Total shareholder yield 4.3% (div 4.3%). Capital returned $5.1B TTM. Source: 10-Q filed 2025-10-30.
| Metric | BMY | Rating | Context |
|---|---|---|---|
| Total Shareholder Yield | 4.3% | Good | Dividend + buyback yield combined |
| Total Capital Returned (TTM) | $5.1B | Good | Dividends + buybacks returned to shareholders |
Sector Rankings
| Metric | Value | Percentile | vs Median |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 14.2% | Top 25% | - |
| Free Cash Flow Margin | 23.3% | Top 5% | - |
| Gross Margin | 70.2% | Top 50% | 1.1x above |
| Operating Margin | 24.2% | Top 25% | 13.3x above |
| Return on Equity (ROE) | 48.2% | Top 25% | - |
| P/E Ratio | 12.6x | N/A | - |
Financial Scorecard
| Metric | BMY | Rating | Sector Context |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 14.2% | Good | Top 25% of sector (median: -5.0%) |
| Free Cash Flow Margin | 23.3% | Excellent | Top 5% of sector (median: 0.0%) |
| Gross Margin | 70.2% | Excellent | Top 50% of sector (median: 64.3%) |
| Debt to Equity Ratio | 193.2% | Warning | High financial leverage |
| P/E Ratio (Price-to-Earnings) | 12.6x | Adequate | Attractively valued |
| Free Cash Flow Yield | 9.7% | Excellent | High cash return |
Frequently Asked Questions
Q: What is BRISTOL MYERS SQUIBB CO's Return on Invested Capital (ROIC)?
BRISTOL MYERS SQUIBB CO (BMY) has a trailing twelve-month Return on Invested Capital (ROIC) of 14.2%. Sector median -5.0%. Source: 10-Q filed 2025-10-30.
Q: What is BRISTOL MYERS SQUIBB CO's Free Cash Flow Margin?
BRISTOL MYERS SQUIBB CO (BMY) has a free cash flow margin of 23.3%, generating $11.4 billion in free cash flow over the trailing twelve months. Source: 10-Q filed 2025-10-30.
Q: What is BRISTOL MYERS SQUIBB CO's P/E ratio and how does it compare to peers?
BRISTOL MYERS SQUIBB CO (BMY) trades at a P/E ratio of 12.6x, which is above the sector median of N/A. EV/Sales 2.9x. FCF yield 9.7%. Source: 10-Q filed 2025-10-30.
Q: Does BRISTOL MYERS SQUIBB CO pay a dividend?
BRISTOL MYERS SQUIBB CO (BMY) currently pays a dividend yield of 4.3%. Total shareholder yield (dividend + buybacks) 4.3%. Source: 10-Q filed 2025-10-30.
Q: How much debt does BRISTOL MYERS SQUIBB CO have?
BRISTOL MYERS SQUIBB CO (BMY) has a debt-to-equity ratio of 1.9x with total debt of $43.1 billion. Net debt $32.1 billion. Source: 10-Q filed 2025-10-30.
Q: What is BRISTOL MYERS SQUIBB CO's revenue and earnings growth?
BRISTOL MYERS SQUIBB CO (BMY) grew revenue by 3.1% year-over-year. EPS +83.1% YoY. Source: 10-Q filed 2025-10-30.
Q: How does BRISTOL MYERS SQUIBB CO compare to competitors in Healthcare?
Compared to other companies in Healthcare, BRISTOL MYERS SQUIBB CO (BMY) shows: ROIC 14.2%, sector median -5.0% (Top 25%). FCF margin 23.3%, sector median 0.0% (Top 5%). Gross margin 70.2%, 5.9pp above sector median. These rankings are based on MetricDuck's analysis of all Healthcare companies with available SEC filings.
Q: What warning signs should I watch for with BRISTOL MYERS SQUIBB CO?
Quantitative warning flags for BRISTOL MYERS SQUIBB CO (BMY): 1) debt/equity 1.9x (above 1.5x threshold). Source: 10-Q filed 2025-10-30.
Data Source: Data sourced from 10-Q filed 2025-10-30. TTM metrics as of Q2 2026.
Methodology: Financial metrics calculated from SEC 10-K and 10-Q filings using standardized formulas. Sector comparisons use peer group based on SIC code.
Scope: This analysis covers SEC filing fundamentals — profitability, cash flow, balance sheet, and valuation metrics. For analyst estimates and price targets, consult sell-side research.
This analysis is for informational purposes only and does not constitute investment advice.